The JAK/STAT Pathway in Cancer: From Molecular Mechanisms to Clinical Applications
MedComm – Oncology · 2026-03 · 5 (1)
DOI: 10.1002/mog2.70063 ↗Kurz gefasst
Fachartikel in der Zeitschrift MedComm – Oncology, online erschienen am 24.03.2026. Verfasst von Yixing Liao und 10 weiteren Autor:innen. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 304 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Natural Science Foundation of China.
Abstract (Originalsprache)
The Janus kinase/signal transducer and activator of transcription (JAK/STAT) signaling pathway is a critical communication hub that translates extracellular signals into gene expression programs. Its aberrant activation serves as a central driver of tumorigenesis, metastasis, and immunosuppression in diverse malignancies. With research expanding from hematologic malignancies to solid tumors, the JAK/STAT pathway has gradually emerged as a promising therapeutic target for cancer treatment. This review systematically analyzes the multi‐dimensional dysregulation of the JAK/STAT pathway, encompassing somatic mutations, epigenetic modifications, and aberrant cytokine networks. We elucidate critical non‐canonical functions that underpin metabolic reprogramming and chromatin stability. Furthermore, we detail the pathway's pivotal role in bridging tumor cells with the microenvironment, focusing on myeloid‐derived suppressor cells (MDSC) recruitment and the reciprocal STAT3/PD‐L1 axis that fuels immune evasion and therapeutic resistance. Finally, we comprehensively evaluate the shifting therapeutic landscape, advocating for a transition from broad‐spectrum kinase inhibitors to high‐precision modalities such as allosteric modulators, proteolysis targeting chimeras (PROTACs), and novel combination strategies. By integrating the advance in the JAK/STAT pathway with cancer, this review underscores the potential of targeting this signaling axis for cancer therapy.
Förderung
- National Natural Science Foundation of China
Zitieren
APA
Liao, Y., Wei, Q., Song, H., Zeng, H., Qi, C., Meng, Y., Zhang, Y., Zhang, Y., Li, W., Li, Y., & Tian, P. (2026). The JAK/STAT Pathway in Cancer: From Molecular Mechanisms to Clinical Applications. MedComm – Oncology, 5(1). https://doi.org/10.1002/mog2.70063
Vancouver
Liao Y, Wei Q, Song H, Zeng H, Qi C, Meng Y, et al. The JAK/STAT Pathway in Cancer: From Molecular Mechanisms to Clinical Applications. MedComm – Oncology. 2026;5(1). doi:10.1002/mog2.70063
BibTeX
@article{Liao2026,
author = {Liao, Yixing and Wei, Qi and Song, Hongjun and Zeng, Hao and Qi, Chang and Meng, Yunchang and Zhang, Yuanyuan and Zhang, Yuanyuan and Li, Weimin and Li, Yalun and Tian, Panwen},
title = {The JAK/STAT Pathway in Cancer: From Molecular Mechanisms to Clinical Applications},
journal = {MedComm – Oncology},
year = {2026},
volume = {5},
number = {1},
doi = {10.1002/mog2.70063}
}
EUVIMED